Page 9 - Numinus Bioscience News Today

PALM BEACH, Fla., Oct. 28, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential…

A glance at some of the days highlights from the Proactive Investors US and Canada newswires

A glance at some of the days highlights from the Proactive Investors US and Canada newswires

Finalized study design and protocol mark major milestone to investigate natural Psilocybin Numinus Wellness Inc.  a leader in psychedelics-focused mental healthcare, is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin extract, previously announced on April 26, 2021 . This major milestone advances Numinus' investigation of its first proprietary ...

The company said the finalized study design and protocol mark a major milestone to investigate natural psilocybin

/PRNewswire/ -- Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the medical cost of...

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 14, 2021 /PRNewswire/ -- Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per

Additional lab facility and federal licence application add expanded contract services to portfolio Numinus Wellness Inc.  a leader in psychedelics-focused mental healthcare, is pleased to announce the expansion of its psychedelics research facility with an additional lab and application for federal licensing, as it continues to broaden its services to support industry research and production while adding new ...

The expanded lab will double the size of the companys research footprint and is slated for completion in the summer of 2022

A glance at some of the days highlights from the Proactive Investors US and Canada newswires